215 related articles for article (PubMed ID: 24756914)
1. Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases.
Homayounfar K; Bleckmann A; Helms HJ; Lordick F; Rüschoff J; Conradi LC; Sprenger T; Ghadimi M; Liersch T
Br J Surg; 2014 Apr; 101(5):550-7. PubMed ID: 24756914
[TBL] [Abstract][Full Text] [Related]
2. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
Choti MA; Thomas M; Wong SL; Eaddy M; Pawlik TM; Hirose K; Weiss MJ; Kish J; Green MR
Ann Surg Oncol; 2016 Feb; 23(2):375-81. PubMed ID: 26561404
[TBL] [Abstract][Full Text] [Related]
3. Effect of specialist decision-making on treatment strategies for colorectal liver metastases.
Jones RP; Vauthey JN; Adam R; Rees M; Berry D; Jackson R; Grimes N; Fenwick SW; Poston GJ; Malik HZ
Br J Surg; 2012 Sep; 99(9):1263-9. PubMed ID: 22864887
[TBL] [Abstract][Full Text] [Related]
4. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
[TBL] [Abstract][Full Text] [Related]
5. Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?
Aubin JM; Bressan AK; Grondin SC; Dixon E; MacLean AR; Gregg S; Tang P; Kaplan GG; Martel G; Ball CG
Can J Surg; 2018 Aug; 61(4):251-256. PubMed ID: 30067183
[TBL] [Abstract][Full Text] [Related]
6. [Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].
Arnold D; Stöltzing O; Timm S; Stein A; Geissler M; Lang H
Z Gastroenterol; 2010 Dec; 48(12):1375-83. PubMed ID: 21125514
[TBL] [Abstract][Full Text] [Related]
7. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
8. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
Garlipp B; Gibbs P; Van Hazel GA; Jeyarajah R; Martin RCG; Bruns CJ; Lang H; Manas DM; Ettorre GM; Pardo F; Donckier V; Benckert C; van Gulik TM; Goéré D; Schoen M; Pratschke J; Bechstein WO; de la Cuesta AM; Adeyemi S; Ricke J; Seidensticker M
Br J Surg; 2019 Dec; 106(13):1837-1846. PubMed ID: 31424576
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of liver metastases from colorectal carcinoma].
Donadon M; Torzilli G
Minerva Chir; 2007 Aug; 62(4):257-67. PubMed ID: 17641586
[TBL] [Abstract][Full Text] [Related]
10. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
Popescu I; Alexandrescu S; Croitoru A; Boros M
Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
[TBL] [Abstract][Full Text] [Related]
11. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
Shah K; Clary B
Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
[TBL] [Abstract][Full Text] [Related]
12. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
[TBL] [Abstract][Full Text] [Related]
14. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
[TBL] [Abstract][Full Text] [Related]
15. The role of chemotherapy in managing patients with resectable liver metastases.
Halfdanarson TR; Kendrick ML; Grothey A
Cancer J; 2010; 16(2):125-31. PubMed ID: 20404609
[TBL] [Abstract][Full Text] [Related]
16. Close collaboration between local and specialist multidisciplinary teams allows 'fast-tracking' of patients with colorectal liver metastases.
Vasudevan SP; Cresswell AB; Wright JM; Rees M; Stiff D; Wordley A; Motson RW
Colorectal Dis; 2013; 15(10):1253-6. PubMed ID: 23790093
[TBL] [Abstract][Full Text] [Related]
17. Evolving roles of oncology pharmacists in Singapore: a survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre.
Chan A; Shih V; Chew L
J Oncol Pharm Pract; 2008 Mar; 14(1):23-9. PubMed ID: 18337437
[TBL] [Abstract][Full Text] [Related]
18. Extending the frontiers of resectability in advanced colorectal cancer.
Chun YS; Vauthey JN
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S52-8. PubMed ID: 18006265
[TBL] [Abstract][Full Text] [Related]
19. The Oncosurge strategy for the management of colorectal liver metastases - an external validation study.
O'Reilly DA; Chaudhari M; Ballal M; Ghaneh P; Wu A; Poston GJ
Eur J Surg Oncol; 2008 May; 34(5):538-40. PubMed ID: 17560066
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy and targeted therapy in patients with liver metastases from colorectal cancer; medical oncologist's point of view.
Mihaylova Zh; Raynov J
J BUON; 2008; 13(3):323-31. PubMed ID: 18979545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
